SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment

Most testosterone (T) replacement therapy (TRT) products have relied on dose titration to achieve eugonadal levels. However, dose titration in clinical practice can be time-consuming, expensive, and subject to errors. TLANDO (LPCN 1021) is a novel oral testosterone undecanoate (TU) product absorbed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: DelConte, Anthony, Patel, Mahesh V, Papangkorn, Kongnara, Chidambaram, Nachiappan, Bruno, Benjamin J, Kim, Kilyoung, Frank, Joel, Khera, Mohit, Miner, Martin, Kaminetsky, Jed, Vignozzi, Linda, Goldstein, Irwin
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Reproductive Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208873/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.684
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars